GelRed Agarose LE |
|||
| 41029-50G | Biotium | 50G | EUR 384 |
|
Description: Minimum order quantity: 1 unit of 50G |
|||
Biotium Laboratories manufactures the gelred biotium reagents distributed by Genprice. The Gelred Biotium reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Biotium. Other Gelred products are available in stock. Specificity: Gelred Category: Biotium
PAGE GelRed Nucleic Acid Gel Stain, 10, 000X in water |
||
| Biotium | 25uL | EUR 60 |
|
Description: Minimum order quantity: 1 unit of 25uL |
||
PAGE GelRed Nucleic Acid Gel Stain, 10, 000X in water |
||
| Biotium | 0.1mL | EUR 88.8 |
|
Description: Minimum order quantity: 1 unit of 0.1mL |
||
CD7 (T-Cell Leukemia Marker) (HuLy-m2) Antibody |
||
| Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD7 (T-Cell Leukemia Marker)(HuLy-m2), CF594 conjugate, Concentration: 0.1mg/mL |
||
Neurofilament phospho (NF-H) (Neuronal Marker) (NE14) Antibody |
||
| Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Neurofilament, phospho (NF-H) (Neuronal Marker) ( NE14), CF594 conjugate, Concentration: 0.1mg/mL |
||
Neurofilament phospho (NF-H) (Neuronal Marker) (NE14) Antibody |
||
| Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Neurofilament, phospho (NF-H) (Neuronal Marker) ( NE14), CF594 conjugate, Concentration: 0.1mg/mL |
||
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
||
| Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), CF594 conjugate, Concentration: 0.1mg/mL |
||
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
||
| Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), CF594 conjugate, Concentration: 0.1mg/mL |
||
CD7 (T-Cell Leukemia Marker) (HuLy-m2) Antibody |
|||
| BNC941252-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD7 (T-Cell Leukemia Marker)(HuLy-m2), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Neurofilament phospho (NF-H) (Neuronal Marker) (NE14) Antibody |
|||
| BNC941253-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Neurofilament, phospho (NF-H) (Neuronal Marker) ( NE14), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Neurofilament phospho (NF-H) (Neuronal Marker) (NE14) Antibody |
|||
| BNC941253-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Neurofilament, phospho (NF-H) (Neuronal Marker) ( NE14), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
|||
| BNC941254-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
|||
| BNC941254-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Prostate Specific Antigen (PSA) (A67-B/E3 + 1A7) Antibody |
|||
| BNC941255-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Prostate Specific Antigen (PSA)(A67-B/E3 + 1A7), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Prostate Specific Antigen (PSA) (A67-B/E3 + 1A7) Antibody |
|||
| BNC941255-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Prostate Specific Antigen (PSA)(A67-B/E3 + 1A7), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
|||
| BNC941256-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
|||
| BNC941256-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CELA3B / ELA3B (Pancreatic Function Marker) (CELA3B/1257) Antibody |
|||
| BNC941257-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CELA3B / ELA3B (Pancreatic Function Marker) (CELA3B/1257),CF594 conjugate, Concentration: 0.1mg/mL |
|||
CELA3B / ELA3B (Pancreatic Function Marker) (CELA3B/1257) Antibody |
|||
| BNC941257-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CELA3B / ELA3B (Pancreatic Function Marker) (CELA3B/1257),CF594 conjugate, Concentration: 0.1mg/mL |
|||
TDP2 / EAPII (TDP2/1258) Antibody |
|||
| BNC941258-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against TDP2 / EAPII (TDP2/1258),CF594 conjugate, Concentration: 0.1mg/mL |
|||
TDP2 / EAPII (TDP2/1258) Antibody |
|||
| BNC941258-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against TDP2 / EAPII (TDP2/1258),CF594 conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
| BNC941259-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Granzyme B (NK/T-Cell Lymphoma Marker) Antibody |
|||
| BNC941259-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Carcinoembryonic Antigen (CEA) / CD66 (C66/1260) Antibody |
|||
| BNC941260-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Carcinoembryonic Antigen (CEA) / CD66 ( C66/1260), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Carcinoembryonic Antigen (CEA) / CD66 (C66/1260) Antibody |
|||
| BNC941260-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Carcinoembryonic Antigen (CEA) / CD66 ( C66/1260), CF594 conjugate, Concentration: 0.1mg/mL |
|||